基于在不平衡数据中改进的支持向量数据描述,预测药物蛋白相互作用
Alireza Khorramfard1, Jamshid Pirgazi1, Ali Ghanbari Sorkhi1
1Department of Electrical and Computer Engineering, University of Science and Technology of Mazandaran, Behshahr, Iran.
预测药物与蛋白质相互作用对于药物发现至关重要. 新的VASVDD方法使用机器学习来提高准确性和效率,优于现有技术.
科学领域:
- 生物信息学是一种生物信息学.
- 计算机化药物发现技术
- 机器学习 机器学习
背景情况:
- 预测药物蛋白相互作用 (DPI) 对于有效的药物发现至关重要.
- 传统的实验室方法用于DPI预测是昂贵和耗时的.
- 计算方法,特别是机器学习,提供了一个更有效的替代方案.
研究的目的:
- 介绍VASVDD,一种用于预测药物蛋白相互作用的新型多步计算方法.
- 在DPI预测中解决不平衡数据集和高维度的挑战.
- 提高药物向相互作用分析的效率和预测性能.
主要方法:
- 从蛋白质氨基酸序列和药物结构中提取特征.
- 使用支持向量数据描述 (SVDD) 进行可靠的数据平衡.
- 采用变量自动编码器 (VAE) 来显著减少尺寸性 (1074到32个特征).
主要成果:
- 在四个不同的生物数据集中,VASVDD显著改善了分类指标 (准确度,灵敏度,特异性,F1分数).
- 该方法在PCA和内核PCA等标准尺寸缩小技术上表现出优异的性能.
- 与现有的最先进的方法相比,VASVDD在多个分类器中实现了更高的AUROC值.
结论:
- VASVDD是一种有效和可通用的工具,用于预测药物向相互作用.
- 该方法为生物信息学应用提供了更高的准确性,稳定性和计算效率.
- 在计算药物发现方面,VASVDD是一个有前途的进步.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
相关概念视频
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Protein-protein Interfaces
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
